The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 102, Issue 8, 2008, Pages 1165-1172

  Carter, John D ^a   Patel, Shalini ^a   Sultan, Farah L ^a   Thompson, Zachary J ^a   Margaux, Hemstreet ^a   Sterrett, Ashley ^a   Carney, Gregory ^a   Murphy, Nancy ^a   Huang, Yangxin ^a   Valeriano, Joanne ^a   Vasey, Frank B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Bisphosphonate; Chronic obstructive pulmonary disease; COPD; Drug therapy; Osteoporosis; Vertebral fracture

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; CORTICOSTEROID; RISEDRONIC ACID; TESTOSTERONE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; VERTEBRA FRACTURE;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CALCIUM; CLINICAL COMPETENCE; DRUG UTILIZATION; GLUCOCORTICOIDS; HUMANS; KYPHOSIS; MALE; MIDDLE AGED; OBSERVER VARIATION; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPINAL FRACTURES; VITAMIN D;

EID: 47349093933     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.03.003     Document Type: Article

References (33)

1. Eastell R., Boyle I.T., Compston J., Cooper C., Fogelman I., Francis R.M., et al. Management of male osteoporosis: report of the UK consensus group. QJM 91 2 (1998) 71-92
2. Olszynski W.P., Shawn Davison K., Adachi J.D., Brown J.P., Cummings S.R., Hanley D.A., et al. Osteoporosis in men; epidemiology, diagnosis, prevention, and treatment. Clin Ther 26 1 (2004) 15-28
3. McEvoy C.E., Ensrud K.E., Bender E., Genant H.K., Griffith J.M., and Niewoehner D.E. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 3 Pt 1 (1998) 704-709
4. Papaioannou A., Parkinson W., Ferko N., Probyn L., Ioannidis G., Jurriaans E., et al. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 14 11 (2003) 913-917
5. Soriano J.B., Visick G.T., Muellerova H., Payvandi N., and Hansell A.L. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128 4 (2005) 2099-2107
6. Yuan H.A., Brown C.W., and Phillips F.M. Osteoporotic spinal deformity: a biomechanical rationale for the clinical consequences and treatment of vertebral body compression fractures. J Spinal Disord Tech 17 3 (2004 Jun) 236-242
7. Truumees E. Medical consequences of osteoporotic vertebral compression fractures. Instr Course Lect 52 (2003) 551-558
8. Jorgensen N.R., Schwarz P., Holme I., Henriksen B.M., Petersen L.J., and Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101 1 (2007 Jan) 177-185
9. Lombardi Jr. I., Oliveira L.M., Mayer A.F., Jardim J.R., and Natour J. Evaluation of pulmonary function and quality of life in women with osteoporosis. Osteoporos Int 16 10 (2005 Oct) 1247-1253
10. Ross P.D., Davis J.W., Epstein R.S., and Wasnich R.D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114 (1991) 919-923
11. Ross P.D., Genant H.K., Davis J.W., Miller P.D., and Wasnich R.D. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int 3 (1993) 120-126
12. Lindsay R., Silverman S.L., Cooper C., Hanley D.A., Barton I., Broy S.B., et al. Risk of new vertebral fracture in the year following fracture. JAMA 285 3 (2001) 320-323
13. Black D.M., Cummings S.R., Karpf D.B., Cauley J.A., Thompson D.E., Nevitt M.C., et al. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348 9041 (1996) 1535-1541
14. Gonnelli S., Cepollaro C., Montagnani A., Bruni D., Caffarelli C., Breschi M., et al. Alendronate treatment in men with primary osteoporosis: a three year longitudinal study. Calcif Tissue Int 73 2 (2003) 133-139
15. Harris S.T., Watts N.B., Genant H.K., McKeever C.D., Hangartner T., Keller M., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized clinical trial. JAMA 282 (1999) 1344-1352
16. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 1344 19 (2001) 1434-1441
17. Gehlbach S.H., Bigelow C., Heimisdottir M., May S., Walker M., and Kirkwood J.R. Recognition of vertebral fracture in a clinical setting. Osteoporos Int 11 7 (2000) 577-582
18. Kim N., Rowe B.H., Raymond G., Jen H., Colman I., Jackson S.A., et al. Underreporting of vertebral fractures on routine chest radiography. AJR Am J Roentgenol 182 2 (2004) 297-300
19. Majumdar S.R., Kim N., Colman A., Chahal A.M., Raymond G., Jen H., et al. Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med 165 8 (2005) 905-909
20. Genant H.K., Jergas M., Palermo L., Nevitt M., Valentin R.S., Black D., et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporosis Fractures Research Group. J Bone Miner Res 11 7 (1996) 984-996
21. Wu C.Y., Li J., Jergas M., and Genant H.K. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporos Int 5 5 (1995) 354-370
22. Black D.M., Palermo L., Nevitt M.C., Genant H.K., Epstein R., San Valentin R., et al. Comparison of the methods for defining prevalent vertebral deformities: the study of osteoporotic fractures. J Bone Miner Res 10 6 (1995) 890-902
23. Delmas P.D., van de Langerijt L., Watts N.B., Eastell R., Genant H., Grauer A., et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 20 4 (2005) 557-563
24. Jiang G., Eastell R., Barrington N.A., and Ferrar L. Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int 15 11 (2004) 887-896
25. Pak C.Y., Ho A., Poindexter J., Peterson R., and Sakhaee K. Quantitation of the incident spinal fractures: comparison of visual detection with quantitative morphometry. Bone 18 4 (1996) 349-353
26. Kado D.M., Browner W.S., Palmero L., Nevitt M.C., Genant H.K., and Cummings S.R. Vertebral fractures and mortality in older women. A prospective study. Arch Intern Med 159 (1999) 1215-1220
27. Genant H.K., Wu C.Y., van Kuijk C., and Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8 (1993) 1137-1148
28. Cobb J.R. Outline for the study of scoliosis. J Am Acad Orthop Surg 5 (1948) 261-275
29. Schneider D.L., von Muhlen D.G., Barrett-Connor E., and Sartoris D.J. Kyphosis does not equal vertebral fractures: the Rancho Bernardo study. J Rheumatol 31 4 (2004) 747-752
30. de Vries F., Bracke M., Leufkens H.G.M., Lammers J.W.J., Cooper C., and van Staa T.P. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56 1 (2007) 208-214
31. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44 (2001) 1496-1503
32. Ensrud K.E., Black D.M., Harris F., Ettinger B., and Cummings S.R. Correlates of kyphosis in older women. The Fracture Intervention Trial Research Group. J Am Geriatr Soc 45 6 (1997) 682-687
33. Bartynski W.S., Heller M.T., Grahovac S.Z., Rothfus W.E., and Kurs-Lasky M. Severe thoracic kyphosis in the older patient in the absence of vertebral fracture: association of extreme curve with age. AJNR Am J Neuroradiol 26 8 (2005) 2077-2085